Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: Its association with DNA methylation alteration and patient outcome

被引:44
作者
Arai, Ed
Ushijima, Saori
Tsuda, Hitoshi [7 ]
Fujimoto, Hiroyuki [4 ]
Hosoda, Fumie [2 ]
Shibata, Tatsuhiro [2 ]
Kondo, Tadashi [3 ]
Imoto, Issei [5 ,6 ]
Inazawa, Johji [5 ,6 ]
Hirohashi, Setsuo
Kanai, Yae [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Canc Genom Project, Tokyo 1040045, Japan
[3] Natl Canc Ctr, Res Inst, Proteome Bioinformat Project, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Div Urol, Tokyo, Japan
[5] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan
[6] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan
[7] Natl Def Med Coll, Dept Pathol 2, Tokorozawa, Saitama 359, Japan
关键词
D O I
10.1158/1078-0432.CCR-08-0443
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose:The aim of this study was to clarify genetic and epigenetic alterations occurring during renal carcinogenesis. Experimental Design: Copy number alterations were examined by array-based comparative genomic hybridization analysis using an array harboring 4,361 bacterial artificial chromosome clones, and DNA methylation alterations on CpG islands of the p16 human MutL homologue I von Hippel-Lindau, and thrombospondin 1 genes and the methylated in tumor (MINT-11, MINT-2, MINT-112, MINT-25, and MINT-31) clones were examined in 51 clear cell renal cell carcinomas (RCC). Results: By unsupervised hierarchical clustering analysis based on copy number alterations, clear cell RCCs were clustered into the two subclasses, clusters A (n = 34) and B (n = 17). Copy number alterations were accumulated in cluster B. Loss of chromosome 3p and gain of 5q and 7 were frequent in both clusters A and B, whereas loss of 1p, 4, 9,13q, and 14q was frequent only in cluster B. The average number of methylated CpG islands in cluster B was significantly higher than those in clusterA. Clear cell RCCs showing higher histologic grades, vascular involvement, renal vein tumor thrombi, and higher pathologic stages were accumulated in cluster B. The recurrence-free and overall survival rates of patients in cluster B were significantly lower than those of patients in cluster A. Multivariate analysis revealed that genetic clustering was a predictor of recurrence-free survival and was independent of histologic grade and pathologic stage. Conclusions: This genetic clustering of clear cell RCC is significantly associated with regional DNA hypermethylation and may become a prognostic indicator for patients with RCC.
引用
收藏
页码:5531 / 5539
页数:9
相关论文
共 33 条
[1]
Alimov A, 2004, INT J ONCOL, V25, P955
[2]
Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues [J].
Arai, Eri ;
Kanai, Yae ;
Ushijima, Saori ;
Fujimoto, Hiroyuki ;
Mukai, Kiyoshi ;
Hirohashi, Setsuo .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (02) :288-296
[3]
Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen [J].
Barocas, Daniel A. ;
Mathew, Susan ;
DelPizzo, Joseph J. ;
Darracott Vaughan, E., Jr. ;
Sosa, R. Ernest ;
Fine, Ronnie G. ;
Akhtar, Mohamed ;
Scherr, Douglas S. .
BJU INTERNATIONAL, 2007, 99 (02) :290-295
[5]
Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma [J].
Brunelli, Matteo ;
Eccher, Albino ;
Gobbo, Stefano ;
Ficarra, Vincenzo ;
Novara, Giacomo ;
Cossu-Rocca, Paolo ;
Bonetti, Franco ;
Menestrina, Fabio ;
Cheng, Liang ;
Eble, John N. ;
Martignoni, Guido .
MODERN PATHOLOGY, 2008, 21 (01) :1-6
[6]
Eble J., 2004, PATHOLOGY GENETICS T, P10
[7]
Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers [J].
Etoh, T ;
Kanai, Y ;
Ushijima, S ;
Nakagawa, T ;
Nakanishi, Y ;
Sasako, M ;
Kitano, S ;
Hirohashi, S .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (02) :689-699
[8]
Structural variation in the human genome [J].
Feuk, L ;
Carson, AR ;
Scherer, SW .
NATURE REVIEWS GENETICS, 2006, 7 (02) :85-97
[9]
PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[10]
Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet? [J].
Guida, M. ;
Colucci, G. .
ANNALS OF ONCOLOGY, 2007, 18 :149-152